This site is intended for health professionals only

At the heart of general practice since 1960

pul jul aug2020 cover 80x101px
Read the latest issue online

Independents' Day

NICE ‘should modify’ COPD diagnosis guideline

NICE should redraw COPD diagnosis guidelines because they are likely causing overdiagnosis in men and underdiagnosis in women, respiratory experts have said.

Dr Mark Levy, a GPSI in respiratory medicine based in Harrow, and Professor Martin Miller, from the University of Birmingham, warn up to 13% of people thought to have COPD may have been misdiagnosed with the condition, while one in eight cases are likely to be missed.

NICE adopted use of a single, ‘pragmatic’ measure of airways obstruction from the Global Initiative for Obstructive Lung Disease (GOLD) in 2010, which means people are diagnosed with COPD if they have a post-bronchodilator ratio of FEV1/FVC cut-off of less than 0.7, regardless of any other factors.

However, writing in a BMJ commentary, Dr Levy and Professor Miller say this is causing over-diagnosis in some patients – particularly older men.  Many of these will have heart disease that is left undiagnosed as a result of their breathlessness being put down to COPD, they say – a risk compounded by the known cardiac side effects of certain COPD inhalers.

Meanwhile evidence shows COPD can be missed in other patients using the NICE/GOLD fixed ratio, particularly women under 50.

The experts call for the NICE criteria to be modified to apply lower limit of normal (LLN) standards – which take into account natural variations in lung function according to age, sex, height and ethnicity – to the FEV1/FVC reading.

In the meantime they say GPs should start using the LLN when assessing patients for COPD.

They write: ‘Adoption of this criterion, which is programmed for spirometry software, will help to improve patient care through more accurate diagnosis of obstructive airflow diseases as well as leading to other investigations for alternative diagnoses when appropriate.’

NICE said guidelines for COPD management are due for review next year when a decision would be made on whether to update the diagnostic criteria.

A spokesperson said: ‘The NICE COPD guideline is due to be reviewed in March 2016; at this point a formal check will be conducted to identify any relevant evidence that may impact the recommendations and a decision will be made as to whether any recommendations need updating. We welcome any new research that will help further develop our guidance.’

Readers' comments (3)

  • Ivan Benett

    I read this article with interest too. The issue is in diagnostic thresholds and simplicity of assessment. It may well be that the diagnostic criteria need review. However the real problem, whatever threshold is taken, is that recorded prevalence is too low. Whether the real prevalence in over 40s is 22% or 13%, either way we need to find more of the patients with COPD if we are to make an impact on their long term health.
    As treatment involves stopping smoking, we should be encouraging this anyway. If they smoke and reach the GOLD threshold, they need to stop smoking anyway, use inhalers for symptomatic relief, and they may benefit from trials of steroids and antibiotics in any case

    Unsuitable or offensive? Report this comment

  • Spirometry is such a crappy way to diagnose copd, just ct chest scan every 20 pack year smoker to see if emphysema is present and there you go diagnosis made and the missing millions found,

    Unsuitable or offensive? Report this comment

  • Simple condition. Stop smoking, lose weight, inhaler and refer. Overcomplicated by scores and percentages.

    Unsuitable or offensive? Report this comment

Have your say